Different from the HDGC tumors in which CDH1 promoter methylation appears to be the predominant inactivating mechanism (around 32%),30 we rarely observed methylation phenomena in HLBC tumors (Table 2 and eTable 7 in Supplement 1). The gene discussed is CDH1; the disease is CDH1-related diffuse gastric and lobular breast cancer syndrome.